Ensign Peak Advisors, Inc Galera Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.39 $138,882 - $267,684	112,002 Added 281.59%	151,777 $197,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $8.28 $50,514 - $329,337	39,775 New	39,775 $153,000
Q1 2021 May 12, 2021	SELL	$8.35 - $12.39 $59,518 - $88,315	-7,128 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$6.96 - $9.12 $12,507 - $16,388	-1,797 Reduced 20.13%	7,128 $64,000
Q1 2020 May 11, 2020	SELL	$5.89 - $17.67 $94,681 - $284,045	-16,075 Reduced 64.3%	8,925 $85,000
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $228,250 - $347,500	25,000 New	25,000 $329,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.